Tirzepatide, a novel medication, is generating significant interest in the healthcare community as a viable treatment for both diabetes, type 2 and weight loss . This dual-action drug works by activating two distinct receptors, GLP-1 and GIP, leading to improved glucose control and significant fat loss in testing. While initial data are encouraging